SGRX is one to avoid, with delisting risk and no clear catalyst behind its 14% jump. Squeeze risk rates 6 out of 10. x.comÂ
ShortSide Research
Short-Selling Research & Analysis Tools
China SXT Pharmaceuticals is a short-squeeze candidate: short interest exceeds 20%, institutional ownership exceeds 100%, no shares are left to borrow and the cost to borrow is over 500%. It has the same setup as other low-float, high-short-interest plays; after coiling all day, a pop on incoming volume is only a matter of time because shorts are trapped. x.com x.comÂ
Space stocks such as Redwire and AST SpaceMobile have run too far on retail chasing and look like shorts into the SpaceX IPO. Government contracts are already priced in, and the stocks price years ahead while ignoring execution risk. The SpaceX IPO should absorb more liquidity as institutions sell the news, leaving retail holding the bag. AST SpaceMobile is the second-biggest space short after EchoStar; sell space stocks before IPO day, though the broader market can stay steady through July. … Show more
Rising Dragon Acquisition, Yunji and Tenon Medical are shorting opportunities because nothing but low float and momentum is holding them up. All three are top gainers with no news or filings. Premarket traders build momentum, retail chases the stock higher, and early buyers then take profits, reversing the move. Shorting no-news top gainers has an excellent success rate over time. x.comÂ
Avis Budget Group looks like a great short on the way down because its roughly 500% rise over the past month appears to be just a short squeeze, with no fundamental reason or even buyout speculation behind it. x.comÂ